Select Medical Q2 estimates: revenue ~$1.67B, Adj EBITDA ~$219M, EPS ~$0.61; in refinancing talks

SELECT MEDICAL HOLDINGS CORP

2023-Q2 EPS reported $1.17 revenue$3,339,508,000

Net operating revenue expected ~$1.67B for Q2 ended June 30, 2023.
Adjusted EBITDA ~$219M; fully diluted EPS ~$0.61.
As of June 30, 2023, cash ~$100M; indebtedness ~$3.75B.
Company in discussions with lenders regarding proposed refinancing of certain debt.
Actual Q2 results to be announced after market close on August 3, 2023.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SELECT MEDICAL HOLDINGS CORP reported second quarter ended June 30, 2023 results: revenue approximately $1.67 billion, EPS approximately $0.61.

Period: second quarter ended June 30, 2023
Revenue: approximately $1.67 billion
EPS: approximately $0.61
Result: preliminary results

Exact text from the filing

Select Medical expects its net operating revenue for its second quarter of 2023 to be approximately $1.67 billion. Select Medical expects earnings excluding interest, income taxes, depreciation and amortization, gain (loss) on early retirement of debt, stock compensation expense, gain (loss) on sale of businesses, and equity in earnings (losses) of unconsolidated subsidiaries, or Adjusted EBITDA, for the second quarter of 2023 to be approximately $219 million. Select Medical expects fully diluted earnings per common share for the second quarter of 2023 to be approximately $0.61.

View on SEC.gov

Browse all earnings releases →

SELECT MEDICAL HOLDINGS CORP filing history →

Source: SEC EDGAR

accession 0001104659-23-082364

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.